Repligen
RGEN
#1855
Rank
C$15.83 B
Marketcap
C$247.79
Share price
6.68%
Change (1 day)
18.36%
Change (1 year)
Categories

Repligen (RGEN) - Total debt

Total debt on the balance sheet as of June 2026 : C$0.98 Billion

According to Repligen 's latest financial reports the company's total debt is C$0.98 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Repligen - Total debt on balance sheet (from 2004 to 2026)

Total debt by year

Year Total debt Change
2025-12-31C$0.94 B-4.05%
2024-12-31C$0.98 B4.31%
2023-12-31C$0.94 B64.5%
2022-12-31C$0.57 B23.03%
2021-12-31C$0.46 B32.84%
2020-12-31C$0.35 B2.11%
2019-12-31C$0.34 B143.96%
2018-12-31C$0.14 B12.97%
2017-12-31C$0.12 B-2.54%
2016-12-31C$0.12 B
2005-03-31C$0.14 M29.94%
2004-03-31C$0.11 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
C$90.50 B 9,046.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
C$60.93 B 6,058.11%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
C$27.67 B 2,696.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$64.17 B 6,385.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
C$27.68 M-97.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
C$0.42 B-56.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$0.57 B-41.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
C$0.41 B-58.16%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$6.01 B 508.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
C$4.33 B 338.20%๐Ÿ‡บ๐Ÿ‡ธ USA